Susan G. Kim is CFO at PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). They have made 9 open-market trades across 1 company since 2021, most recently 2024-09-30.
CIK 0001825421
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PACB | 695,654 | $1.8M |
Shares reported on the most recent Form 4, priced at the 2024-10-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PACB | SELL | 2024-09-30 | 2024-10-02 | $1.72 | $34K | +28.1% | +52.5% | +14.4% |
| PACB | SELL | 2024-03-04 | 2024-03-06 | $4.87 | $26K | -16.0% | -23.3% | -58.8% |
| PACB | SELL | 2024-02-16 | 2024-02-21 | $5.95 | $273K | -4.7% | -28.1% | -64.3% |
| PACB | SELL | 2023-09-29 | 2023-09-29 | $8.44 | $325K | +9.5% | -13.8% | +25.6% |
| PACB | SELL | 2023-03-03 | 2023-03-06 | $9.49 | $48K | -3.1% | +20.2% | +48.9% |
| PACB | SELL | 2023-02-17 | 2023-02-22 | $10.27 | $9K | -3.5% | +1.3% | +32.3% |
| PACB | SELL | 2022-09-29 | 2022-10-03 | $5.61 | $146K | +8.5% | +34.0% | +31.7% |
| PACB | SELL | 2022-02-17 | 2022-02-22 | $11.06 | $12K | -0.3% | -9.7% | -46.4% |
| PACB | SELL | 2021-09-29 | 2021-10-01 | $25.75 | $522K | -6.2% | +7.9% | -18.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.